Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMRE: Testosterone in Transgender Men
NCT05649605Recruiting
- Sponsor
- Karolinska University Hospital
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Randomised, double-blind trial in gender dysphoria (GD) comparing Testosterone with Placebo (2 arms). Primary endpoint: Transgender Congruence Scale at 6 weeks. Started Mar 2023; status: recruiting.
02
Drugs
testosterone undecanoate
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT05649605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05649605.